Zhejiang CONBA Pharmaceutical Co.,Ltd.

XSSC:600572 Stock Report

Market Cap: CN¥11.6b

Zhejiang CONBA PharmaceuticalLtd Future Growth

Future criteria checks 3/6

Zhejiang CONBA PharmaceuticalLtd is forecast to grow earnings and revenue by 24.8% and 16.8% per annum respectively. EPS is expected to grow by 24.1% per annum. Return on equity is forecast to be 11.2% in 3 years.

Key information

24.8%

Earnings growth rate

24.1%

EPS growth rate

Pharmaceuticals earnings growth18.7%
Revenue growth rate16.8%
Future return on equity11.2%
Analyst coverage

Low

Last updated23 Aug 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:600572 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20269,6621,009N/A1,3322
12/31/20258,610890N/A1,3272
12/31/20247,533767N/A9951
9/30/20246,462487480699N/A
6/30/20246,417458537765N/A
3/31/20246,426523750977N/A
12/31/20236,733592689899N/A
9/30/20236,6967521,0201,295N/A
6/30/20236,6846629651,242N/A
3/31/20236,4305398931,186N/A
12/31/20226,0003588641,155N/A
9/30/20226,1412,027453856N/A
6/30/20226,5301,984355846N/A
3/31/20226,6782,073251782N/A
12/31/20216,5682,017310891N/A
9/30/20216,2821296731,150N/A
6/30/20215,8342157831,232N/A
3/31/20215,8213196451,128N/A
12/31/20205,9094537891,250N/A
9/30/20205,918-276414838N/A
6/30/20206,313-252572925N/A
3/31/20206,707-3427331,018N/A
12/31/20196,768-346657926N/A
9/30/20196,855515723971N/A
6/30/20196,978652365710N/A
3/31/20196,975726238606N/A
12/31/20187,018815161549N/A
9/30/20187,067879107531N/A
6/30/20186,644880N/A633N/A
3/31/20185,979790N/A656N/A
12/31/20175,294711N/A714N/A
9/30/20175,266598N/A784N/A
6/30/20175,311519N/A839N/A
3/31/20175,640477N/A925N/A
12/31/20166,020441N/A970N/A
9/30/20166,092275N/A1,178N/A
6/30/20166,141308N/A1,077N/A
3/31/20165,882468N/A960N/A
12/31/20155,302440N/A831N/A
9/30/20154,758770N/A548N/A
6/30/20154,114704N/A562N/A
3/31/20153,746539N/A666N/A
12/31/20143,582552N/A617N/A
9/30/20143,398509N/A478N/A
6/30/20143,212499N/A325N/A
3/31/20142,985451N/A176N/A
12/31/20132,924417N/A235N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600572's forecast earnings growth (24.8% per year) is above the savings rate (2.8%).

Earnings vs Market: 600572's earnings (24.8% per year) are forecast to grow slower than the CN market (26.3% per year).

High Growth Earnings: 600572's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 600572's revenue (16.8% per year) is forecast to grow faster than the CN market (13.9% per year).

High Growth Revenue: 600572's revenue (16.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600572's Return on Equity is forecast to be low in 3 years time (11.2%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y